Cardinal Health Inc. has been a topic of much discussion lately. While the stock value has seen some decline amidst market improvement, experts are still suggesting it be retained in investor portfolios. Investment firms are moving shares around, with both
Duality Advisers LP and
Susquehanna Portfolio Strategies LLC making significant trades. The company's Board of Directors approved an increase in the quarterly dividend, an action often perceived as an optimistic future projection.
Cardinal Health is also making strategic moves in the market by acquiring
Specialty Networks and its PPS Analytics platform. The company has also recently released an annual research report on their progress in biosimilars. Despite lowering its profit forecast for its medical unit, the firm managed to beat Q3 earnings and raised its 2024 outlook.
The company has been restructuring with a new business model and focusing on technological advances, such as AI, in their operations. In terms of ESG initiatives, the company recently released its Fiscal 2023 report, which lays out their goals and actions.
Lastly, the firm's contract with OptumRx will not be renewed after June, a decision that has caused some speculation and concern amongst investors.
Cardinal Health CAH News Analytics from Tue, 15 Aug 2023 07:00:00 GMT to Sun, 14 Jul 2024 21:37:05 GMT -
Rating 1
- Innovation 5
- Information 7
- Rumor 0
